Rezolute (RZLT) is poised for growth with key Phase 3 trial results ahead. Ersodetug targets both congenital and ...

Many North Americans, no matter how accepting they are of biotechnology in crops, are more queasy when it comes to tinkering ...

Poster presentation highlights promising results from Phase 1b/2 TENACITY-01 study of CTD402 in T-Cell and myeloid leukemias ...

Data from Structure Therapeutics and WAVE Life Sciences show that threats to the incumbents’ dominance are on the way.

The FDA granted Breakthrough Therapy status to Incyte's experimental treatment for a rare blood cancer. Incyte stock fell ...

Garo Armen serves as chairman and CEO of Agenus Inc., a clinical-stage biotechnology company based in Lexington, ...

Three biotechnology companies based in Ventura County recently received some good news from the U.S. Food and Drug Administration, gaining either approval or reviews for their treatments. These ...

Massachusetts Institute of Technology professor Phillip Sharp co-founded Alnylam with several others in 2002. It wasn't Sharp ...

Medicus Pharma Ltd. (Nasdaq:MDCX) is a precision guided biotech/life sciences company focused on accelerating the clinical ...

Agricultural producers face mixed policy wins and ongoing challenges as trade disputes and regulatory battles continue.

Kura and partner Kyowa Kirin announced the Nov. 13 approval in a company statement, and CEO Troy Wilson described the ...

New legislation proposed by a bipartisan and bicameral group of Congressional legislators and supported by the North Carolina ...